Scott E. Plevy

13.3k total citations · 2 hit papers
134 papers, 8.8k citations indexed

About

Scott E. Plevy is a scholar working on Genetics, Immunology and Epidemiology. According to data from OpenAlex, Scott E. Plevy has authored 134 papers receiving a total of 8.8k indexed citations (citations by other indexed papers that have themselves been cited), including 64 papers in Genetics, 49 papers in Immunology and 45 papers in Epidemiology. Recurrent topics in Scott E. Plevy's work include Inflammatory Bowel Disease (60 papers), Microscopic Colitis (40 papers) and Gut microbiota and health (18 papers). Scott E. Plevy is often cited by papers focused on Inflammatory Bowel Disease (60 papers), Microscopic Colitis (40 papers) and Gut microbiota and health (18 papers). Scott E. Plevy collaborates with scholars based in United States, Germany and Japan. Scott E. Plevy's co-authors include Stephen T. Smale, Hans D. Brightbill, Robert L. Modlin, Antonia R. Sepulveda, Stephan R. Targan, Erin C. Steinbach, Michael V. Norgard, John T. Belisle, Stephan R. Krutzik and Daniel H. Libraty and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Scott E. Plevy

125 papers receiving 8.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like Receptors

1999 1.4k citations Hans D. Brightbill, Scott E. Plevy et al. profile →
Whole-Virome Analysis Sheds Light on Viral Dark Matter in Inflammatory Bowel Disease

2019 284 citations Adam G. Clooney, Thomas Sutton et al. Cell Host & Microbe profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott E. Plevy United States	51	3.6k	2.7k	2.5k	2.4k	1.2k	134	8.8k
Clara Abraham United States	40	3.6k 1.0×	2.8k 1.0×	1.5k 0.6×	2.5k 1.1×	1.4k 1.1×	82	8.0k
Susanna Nikolaus Germany	40	2.4k 0.6×	4.0k 1.5×	2.0k 0.8×	2.4k 1.0×	1.8k 1.5×	96	8.1k
Theresa T. Pizarro United States	51	4.4k 1.2×	2.7k 1.0×	1.3k 0.5×	3.5k 1.5×	2.0k 1.7×	142	9.4k
Fabio Cominelli United States	61	4.6k 1.3×	4.1k 1.5×	2.3k 0.9×	3.8k 1.6×	2.3k 1.9×	248	12.1k
Jan Wehkamp Germany	51	3.6k 1.0×	3.2k 1.2×	1.7k 0.7×	4.6k 1.9×	1.6k 1.4×	159	11.2k
Torsten Kucharzik Germany	50	2.6k 0.7×	3.7k 1.4×	2.6k 1.0×	1.8k 0.8×	2.5k 2.1×	198	9.2k
Raja Atreya Germany	48	3.3k 0.9×	3.7k 1.3×	2.0k 0.8×	1.9k 0.8×	1.6k 1.4×	269	8.8k
Kevin J. Maloy United Kingdom	43	6.5k 1.8×	2.1k 0.8×	1.2k 0.5×	3.0k 1.2×	1.5k 1.2×	63	10.1k
Holm H. Uhlig United Kingdom	41	4.8k 1.3×	2.3k 0.8×	1.5k 0.6×	2.3k 1.0×	1.9k 1.6×	127	8.9k
Levinus A. Dieleman Canada	50	2.1k 0.6×	3.7k 1.4×	2.1k 0.8×	3.8k 1.6×	2.0k 1.7×	180	9.4k

Countries citing papers authored by Scott E. Plevy

Since Specialization

Citations

This map shows the geographic impact of Scott E. Plevy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott E. Plevy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott E. Plevy more than expected).

Fields of papers citing papers by Scott E. Plevy

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott E. Plevy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott E. Plevy. The network helps show where Scott E. Plevy may publish in the future.

Co-authorship network of co-authors of Scott E. Plevy

This figure shows the co-authorship network connecting the top 25 collaborators of Scott E. Plevy. A scholar is included among the top collaborators of Scott E. Plevy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott E. Plevy. Scott E. Plevy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Ertürk-Hasdemir, Deniz, Sungwhan F. Oh, Nihal A. Okan, et al.. (2019). Symbionts exploit complex signaling to educate the immune system. Proceedings of the National Academy of Sciences. 116(52). 26157–26166. 88 indexed citations

Clooney, Adam G., Thomas Sutton, Andrey N. Shkoporov, et al.. (2019). Whole-Virome Analysis Sheds Light on Viral Dark Matter in Inflammatory Bowel Disease. Cell Host & Microbe. 26(6). 764–778.e5. 284 indexed citations breakdown →

Manthey, Carl L., Beverley A. Moore, Yanqing Chen, et al.. (2019). The CSF-1-receptor inhibitor, JNJ-40346527 (PRV-6527), reduced inflammatory macrophage recruitment to the intestinal mucosa and suppressed murine T cell mediated colitis. PLoS ONE. 14(11). e0223918–e0223918. 18 indexed citations

Tilstra, Jeremy S., Daniel F. Gaddy, Jing Zhao, et al.. (2014). Pharmacologic IKK/NF-κB inhibition causes antigen presenting cells to undergo TNFα dependent ROS-mediated programmed cell death. Scientific Reports. 4(1). 3631–3631. 25 indexed citations

Steinbach, Erin C. & Scott E. Plevy. (2013). The Role of Macrophages and Dendritic Cells in the Initiation of Inflammation in IBD. Inflammatory Bowel Diseases. 20(1). 166–175. 191 indexed citations

Plevy, Scott E., Mark S. Silverberg, S. Lockton, et al.. (2013). Combined Serological, Genetic, and Inflammatory Markers Differentiate Non-IBD, Crohnʼs Disease, and Ulcerative Colitis Patients. Inflammatory Bowel Diseases. 19(6). 1139–1148. 97 indexed citations

Shinzaki, Shinichiro, Hideki Iijima, Hironobu Fujii, et al.. (2012). Lectin-based Immunoassay for Aberrant IgG Glycosylation as the Biomarker for Crohnʼs Disease. Inflammatory Bowel Diseases. 19(2). 321–331. 36 indexed citations

Elloumi, Houda Zghal, Nitsan Maharshak, Kavitha N. Rao, et al.. (2012). A Cell Permeable Peptide Inhibitor of NFAT Inhibits Macrophage Cytokine Expression and Ameliorates Experimental Colitis. PLoS ONE. 7(3). e34172–e34172. 49 indexed citations

Maharshak, Nitsan & Scott E. Plevy. (2011). A Crohn's Disease Patient Who Does Not Respond to Infliximab: What Is Next?. Clinical Gastroenterology and Hepatology. 9(12). 1033–1038. 3 indexed citations

10.

Rapaka, Rekha R., David Ricks, John F. Alcorn, et al.. (2010). Conserved natural IgM antibodies mediate innate and adaptive immunity against the opportunistic fungus Pneumocystis murina. The Journal of Experimental Medicine. 207(13). 2907–2919. 103 indexed citations

11.

Han, Xiaonan, Kanji Uchida, Ingrid Jurickova, et al.. (2008). Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in Murine Ileitis and Progressive Ileal Crohn's Disease. Gastroenterology. 136(4). 1261–1271.e3. 93 indexed citations

12.

Davé, Shaival H., Jeremy S. Tilstra, Katsuyoshi Matsuoka, et al.. (2007). Amelioration of Chronic Murine Colitis by Peptide-Mediated Transduction of the IκB Kinase Inhibitor NEMO Binding Domain Peptide. The Journal of Immunology. 179(11). 7852–7859. 73 indexed citations

13.

Bogunovic, Milena, Shaival H. Davé, Jeremy S. Tilstra, et al.. (2007). Enteroendocrine cells express functional Toll-like receptors. American Journal of Physiology-Gastrointestinal and Liver Physiology. 292(6). G1770–G1783. 187 indexed citations

14.

Zhou, Hui, Huabao Xiong, Hongxing Li, et al.. (2004). Microtubule-Associated Serine/Threonine Kinase-205 kDa and Fcγ Receptor Control IL-12 p40 Synthesis and NF-κB Activation. The Journal of Immunology. 172(4). 2559–2568. 15 indexed citations

15.

Hale, William, Martin H. Floch, Robert Burakoff, et al.. (2004). Indeterminate Colitis. Journal of Clinical Gastroenterology. 38(Supplement 1). S57–S57.

16.

Xiong, Huabao, Chen Zhu, Hongxing Li, et al.. (2003). Complex Formation of the Interferon (IFN) Consensus Sequence-binding Protein with IRF-1 Is Essential for Murine Macrophage IFN-γ-induced iNOS Gene Expression. Journal of Biological Chemistry. 278(4). 2271–2277. 61 indexed citations

17.

Taylor, Kent D., Huiying Yang, Carol J. Landers, et al.. (2001). ANCA pattern and LTA haplotype relationship to clinical responses to anti-TNF antibody treatment in Crohn's disease. Gastroenterology. 120(6). 1347–1355. 176 indexed citations

18.

Brightbill, Hans D., Scott E. Plevy, Robert L. Modlin, & Stephen T. Smale. (2000). A Prominent Role for Sp1 During Lipopolysaccharide- Mediated Induction of the IL-10 Promoter in Macrophages. The Journal of Immunology. 164(4). 1940–1951. 238 indexed citations

19.

Vasiliauskas, Eric A., et al.. (2000). Factors predictive of response to cyclosporin treatment for severe, steroid-resistant ulcerative colitis. The American Journal of Gastroenterology. 95(8). 2000–2008. 70 indexed citations

20.

Plevy, Scott E., et al.. (1997). Multiple Control Elements Mediate Activation of the Murine and Human Interleukin 12 p40 Promoters: Evidence of Functional Synergy between C/EBP and Rel Proteins. Molecular and Cellular Biology. 17(8). 4572–4588. 276 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact